Nedogoda S V, Marchenko I V, Chaliabi T A, Tsoma V V, Brel' U A, Prokhorova E A
Kardiologiia. 2005;45(11):24-6.
Clinical effectiveness and tolerability of o.d. use of fixed dose combinations of perindopril (4 mg) with indapamide (1.25 mg) (Noliprel forte) and captopril (50 mg) with hydrochlorothiazide (25 mg) (Capozide) were compared in a randomized study on 40 patients with I-II degree high and very high risk hypertension. Study duration was 6 months, number of patients in each of parallel groups -- 20. Antihypertensive activity, ability to decrease left ventricular hypertrophy, to improve arterial elasticity and T/P parameter of perindopril (4 mg) -- indapamide (1.25 mg) combination was found to be superior to those of captopril (50 mg) -- hydrochlorothiazide (25 mg) combination.
在一项针对40例I-II级高危和极高危高血压患者的随机研究中,比较了口服培哚普利(4毫克)与吲达帕胺(1.25毫克)(复代文)和卡托普利(50毫克)与氢氯噻嗪(25毫克)(复方卡托普利)固定剂量组合的临床疗效和耐受性。研究持续时间为6个月,每个平行组的患者数量为20例。结果发现,培哚普利(4毫克)-吲达帕胺(1.25毫克)组合的降压活性、降低左心室肥厚的能力、改善动脉弹性的能力以及T/P参数均优于卡托普利(50毫克)-氢氯噻嗪(25毫克)组合。